104 related articles for article (PubMed ID: 33130741)
21. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
22. Metastasizing ectopic thymoma arising in the right thoracic cavity and mimicking diffuse pleural mesothelioma--an autopsy study of a case with review of literature.
Honma K; Shimada K
Wien Klin Wochenschr; 1986 Jan; 98(1):14-20. PubMed ID: 3953100
[TBL] [Abstract][Full Text] [Related]
23. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
[TBL] [Abstract][Full Text] [Related]
24. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
25. A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).
Rabasseda X
Drugs Today (Barc); 2015 Sep; 51(9):559-67. PubMed ID: 26488035
[TBL] [Abstract][Full Text] [Related]
26. Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread.
Chen KC; Hsieh YS; Tseng YF; Shieh MJ; Chen JS; Lai HS; Lee JM
PLoS One; 2015; 10(7):e0133230. PubMed ID: 26193470
[TBL] [Abstract][Full Text] [Related]
27. [Outpatient chemotherapy for advanced lung cancer].
Okazaki M; Katakami N; Nishio C; Fujita S; Kaneshiro E; Nishimura T; Ikeda A; Hasegawa T; Umeda B
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1391-5. PubMed ID: 11681246
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
[TBL] [Abstract][Full Text] [Related]
29. Multimodality therapy for thymoma patients with pleural dissemination.
Nakamura S; Kawaguchi K; Fukui T; Hakiri S; Ozeki N; Mori S; Goto M; Hashimoto K; Ito T; Yokoi K
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):524-529. PubMed ID: 30725276
[TBL] [Abstract][Full Text] [Related]
30. The role of radiation therapy in thoracic tumors.
Kong FM; Zhao L; Hayman JA
Hematol Oncol Clin North Am; 2006 Apr; 20(2):363-400. PubMed ID: 16730299
[TBL] [Abstract][Full Text] [Related]
31. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.
Maruyama R; Suemitsu R; Okamoto T; Kojo M; Aoki Y; Wataya H; Eguchi T; Nishiyama K; Seto T; Ichinose Y
Oncology; 2006; 70(5):325-9. PubMed ID: 17164588
[TBL] [Abstract][Full Text] [Related]
32. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
33. [Hyperthermic intrathoracic chemotherapy in thoracic surgery].
Hofmann HS; Ried M
Chirurg; 2019 Aug; 90(8):681-694. PubMed ID: 31218434
[TBL] [Abstract][Full Text] [Related]
34. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.
Kawasaki H; Taira N; Ichi T; Yohena T; Kawabata T; Ishikawa K
Eur J Surg Oncol; 2014 Sep; 40(9):1151-5. PubMed ID: 24703656
[TBL] [Abstract][Full Text] [Related]
35. Atypical thymoma: a report of seven patients.
Baran JL; Magro CM; King MA; Williams TE; Ross P
Ann Thorac Surg; 2004 Aug; 78(2):411-6. PubMed ID: 15276487
[TBL] [Abstract][Full Text] [Related]
36. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
37. Total remission of thymus carcinoma after treatment with intravenous immunoglobulin.
Murie-Fernández M; Gurpide A; de la Cruz S; de Castro P
Clin Transl Oncol; 2006 Sep; 8(9):697-9. PubMed ID: 17005475
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S
Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
[TBL] [Abstract][Full Text] [Related]
40. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
Loehrer PJ; Wang W; Johnson DH; Aisner SC; Ettinger DS;
J Clin Oncol; 2004 Jan; 22(2):293-9. PubMed ID: 14722038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]